Therapy

Bilovol O. M., Nemtsova V. D., Potapenko H. V.
Impact of nonalcoholic fatty liver disease on endothelium of patients with arterial hypertension and hypothyroidism
16 - 20
Kapustnyk V. A., Melnyk O. H., Arkhipkina O. L., Istomina O. V., Sanina K. I.
Functional myocardium assessment in patients with chronic obstructive pulmonary disease and hypertensive disease
21 - 24
Berezniakov I. H., Pozhar V. Y., Doroshenko O. V., Sydorov D. Yu., Lebedynska M. M.
Dynamics of changes of inflammation indicators in patients with community−acquired pneumonia and concomitant chronic heart failure
25 - 28
Rudenko T. M., Smiianova Yu. O., Vlasenko O. M., Butikova O. O., Samburh Ya. Yu.
Daily blood pressure features in patients with hypertension and dyslipidemia under influence of treatment
13 - 17
Kushnirenko I. V.
The ability of buccal epithelial cells to adhesion of Candida albicans in gastroenterological patients with candidiasis of the upper digestive tract mucosa
18 - 23
Kovalova O. M., Ivanchenko S. V., Honchar O. V., Latohuz Yu. I.
Ambulatory blood pressure monitoring in hypertensive patients with overweight and obesity
5 - 10
Kravchun P. H., Kadykova O. I., Ryndina N. H., Molotiahin D. H.
The role of G−308A variant of tumor necrosis factor−α gene in development of obesity in patients with coronary artery disease
11 - 13
Korzh O. M., Krasnokutskyi S. V.
Diagnosis and treatment of gout
14 - 17
Ashcheulova T. V., Ambrosova T. M.
Diagnostic approaches to gluсometabolic categories verification: views evolution
17 - 20
Kapustnyk V. A., Arkhipkina O. L.
Structural and functional state of the myocardium in patients with hypertension and chronic obstructive pulmonary disease
21 - 26
Kompaniets K. M.
The use of alpha−lipoic acid in patients with chronic acalculous cholecystitis in combination with coronary artery disease
27 - 29
Berezniakov V. I., Korzh O. M.
The content of procalcitonin and galectin−3 in the blood of patients with community−acquired pneumonia and concomitant chronic heart failure and without it
13 - 16
Makharynska O. S., Lebedynska M. M., Sidorov D. Yu., Pozhar V. I., Shop I. V., Doroshenko O. V.
The role of cytokine in differential diagnosis and treatment optimization at community acquired pneumonia in patients with diabetes mellitus
17 - 19
Taktashov G. S.
The role of microelementosis in pathogenesis of respiratory disorders at chronic rheumatic heart disease
5 - 8
Chuchelina O. O.
Adipokines of adipose tissue and their role in progression of renal disease
24 - 28
Vlasenko O. M.
Relationship between daily blood pressure profile and a marker of chronic systemic inflammation in patients with stage 2 essential hypertension with microalbuminuria
29 - 33
Ambrosova T. M., Ashcheulova T. V., Smyrnova V. I.
Antihypertensive therapy effects from the perspective of evidence−based medicine
22 - 25
Radzishevska Ya. K.
Echographic markers of vascular and cardiac disorders in patients with arterial hypertension and arterial hypertension associated with type 2 diabetes mellitus
26 - 31
Ambrosova T. N.
Endothelial dysfunction at hypertension
16 - 21
Lukyanov I. E., Kozin Yu. I., Belovol A. N.
The changes in indicators of congenital immunity in patients with mixed urogenital protozoan viral infection when ozone therapy is applied
22 - 29
Ambrosova T. N.
Therapeutic correction of atherogenic dyslipidemia at metabolic syndrome
50 - 55
Lukianov I. E., Kozin Yu. I., Belovol A. N.
The peculiarities of lipid peroxidation processes and antioxidant protection in patients with combined protozoal urogenital mixed infection at ozone therapy
56 - 61
Belovol A. N., Kravchun P. G., Trifonova N. S., Ryndina N. G.
The state of the pro−inflammatory cytokine level in patients with unstable angina and type 2 diabetes mellitus depending on functional class of chronic heart failure
40 - 42
Isayeva A. S.
Progesterone and its influence on the cardiovascular system in women in early postmenopausal period
43 - 47
Ambrosova T. N., Kovaliova O. N., Ascheulova T. V.
The influence of inhibitor of activator of plasminogen−1 on cardiometabolic markers in patients with combined arterial hypertension and obesity
39 - 43
Mikhailova Yu. A., Kravchun P. G., Petiunina O. V., Lapshina L. A.
The influence of cardioprotection on the state of hemodyncmics at treatment of cardiorenal syndrome in patients with chronic heart failure and chronic kidney disease
44 - 49
Ryndina N. G.
Renal dysfunction and peculiarities of iron metabolism in patients with chronic heart failure of various functional classes and chronic kidney disease
50 - 52
Kravchun P. G., Mikhaylova Yu. A., Lapshina L. A., Petunina O. V.
The changes in the level of cytokines, glomerotubular markers, cardiohemodynamics in chronic heart failure and its combination with kidney disease
43 - 48
Volkova Yu. V.
Influence of prevention of thromboembolic complications on the course of post−operative period in gerontological patients with multiple injuries
49 - 52
Olenikov V. E., Sergatskaya N. V., Tomashevskaya Yu. A.
Association of obesity and carbohydrate metabolism disorders and sleep apnea syndrome
31 - 39
Korzh A. N.
Contemporary approaches to obesity prevention
39 - 43
Kravchun P. G., Kadykova O. I.
Clinical, hemodynamic and biochemical effects of Ramipril in patients with type 2 diabetes mellitus and arterial hypertension
43 - 47
Kadykova O. I.
The role of fatty tissue hormones in development of insulin resistance in patients with hypertension disease and type 2 diabetes mellitus
54 - 57
Guseinova Sh. R.
Efficacy of omega−3 PUFA in patients with arterial hypertension associated with metabolic syndrome and accompanying type 2 diabetes mellitus
58 - 62
Stadnikova A. V., Lebed L. V.
Sarcoidosis: emergency states
58 - 62
Kapustnik V. A., Arkhipkina O. L.
Immune changes in patients with vibration disease
53 - 55
Kapustnik V. A., Arkhipkina O. L.
Neuron network simulation at prognosis of the character of the course of vibration sickness accompanied by chronic obstructive pulmonary disease
42 - 45
Kovaliova O. N., Kravchenko N. A.
Advantages of combination drug therapy in correction of dyslipidemia in metabolic syndrome and type 2 diabetes mellitus
71 - 78
Korpachova−Zinych O. V., Chekalskaya N. O., Savitskaya V. V.
Androgen metabolism during postmenopause in women with type 2 diabetes mellitus
79 - 82
Go on Top